A Pilot Study of Differences in Antibody Responses of Intradermal and Intramuscular Injections of Botulinum Toxin Type A.

Dermatol Ther (Heidelb) · 2025 · PMC12549475 · PMID 40911274

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Although the injection route did not affect the percentage of specific hIgG against functional sites and anti-complexing protein antibodies, intradermal injection of BoNT/A showed a trend toward increasing the production of total hIgG against BoNT/A (Fig. 1 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.